Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study

Objective To investigate the causal role of lipid or apolipoprotein traits in intracerebral hemorrhage (ICH) and determine the effect of lipid‐lowering interventions on the disease. Methods Two‐sample Mendelian randomization (MR) analyses were conducted to evaluate the associations of high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol (LDL‐C), triglycerides (TG), apolipoprotein (Apo)B and ApoA1 levels with risks for ICH, and those of LDL‐C‐ ( HMGCR , PCSK9 , and NPC1L1 ) and TG‐lowering targets ( LPL and APOC3 ) with ICH. Results Increased levels of ApoB was associated with a decreased risk of overall ICH (OR 0.623, 95% CI 0.413–0.940; p = 0.024) and lobar ICH (OR 0.579, 95% CI 0.342–0.979; p = 0.042). The inverse relationship remained stable in multivariable MR. In addition, elevated TGs showed a causal effect on lobar ICH in multivariable MR (OR 1.600, 95% CI 1.009–2.537; p = 0.046). The LDL‐C‐reducing genetic variation alleles at or near the HMGCR gene (mimicking the effect of statins) were predicted to increase the overall and deep ICH risk. Additionally, genetic variation at or near the APOC3 gene suggested that genetically reducing the activity of APOC3 (mimicking antisense anti‐apoC3 agents) was predicted to decrease lobar ICH. Interpretation Genetically predicted elevated ApoB may have a protective effect on overall ICH and lobar ICH, whereas elevated TG was associated with a higher risk of lobar ICH conditional on LDL‐C and ApoB. MR analysis supports the conclusion that statins may increase the risk of overall and deep ICH independent of their lipid‐lowering effect. More specific lipid‐lowering targets may end up being the future. ANN NEUROL 2022;92:390–399